摘要
在由蛋白质突变引起的许多构象性疾病中,细胞内的交通被破坏,导致减少或废除受影响蛋白的功能。Pharmacoperones(从“药物分子伴侣”)的化合物进入细胞并作为分子支架帮助错误折叠的突变蛋白的正确折叠,采用稳定的低能构象与适当的适当的胞内运输。Pharmacoperone的使用代表治疗错误折叠疾病最具前景的治疗方法。这类药物在体外和体内,在修复功能的突变体,错误折叠的蛋白质上已经成功了,包括酶、膜受体和离子通道。在这里,我们描述修复错误折叠的G蛋白偶联受体功能的策略,主要是促性腺激素释放激素受体,它已作为Pharmacoperone药品开发的一个有价值的模型,以更好地了解这一类特殊的化合物怎么由目标蛋白检测到正确的路由、表达和功能。
关键词: 构象病,促性腺激素释放激素受体,促性腺激素释放激素,促性腺功能低下,错误折叠的受体,药物分子伴侣,Pharmacoperones
图形摘要
Current Drug Targets
Title:Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive Molecules
Volume: 17 Issue: 13
Author(s): Alfredo Ulloa-Aguirre, P. Michael Conn
Affiliation:
关键词: 构象病,促性腺激素释放激素受体,促性腺激素释放激素,促性腺功能低下,错误折叠的受体,药物分子伴侣,Pharmacoperones
摘要: In many conformational diseases caused by protein mutations, the intracellular traffic of the misfolded protein is compromised, leading to reduced or abolished function of the affected protein. Pharmacoperones (from “pharmacological chaperones”) are compounds that enter cells and serve as a molecular scaffold to aid misfolded mutant proteins to fold properly and adopt a stable, low-energy native conformation compatible with proper intracellular trafficking. The use of pharmacoperones represents the most promising therapeutic approach to treat misfolding disorders. This class of drugs has succeeded, in vitro and in vivo, in rescuing function of mutant, misfolded proteins, including enzymes, membrane receptors and ion channels. Here we describe the strategies to rescue function of misfolded G protein-coupled receptors, mainly of the gonadotropin-releasing hormone receptor, which has served as a valuable model for the development of pharmacoperone drugs and to better understand how this class of particular compounds is sensed by the target protein to correct routing, expression and function.
Export Options
About this article
Cite this article as:
Alfredo Ulloa-Aguirre, P. Michael Conn , Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive Molecules, Current Drug Targets 2016; 17 (13) . https://dx.doi.org/10.2174/1389450117666160307143345
DOI https://dx.doi.org/10.2174/1389450117666160307143345 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
DAB389EGF Fusion Protein Therapy of Refractory Glioblastoma Multiforme
Current Pharmaceutical Biotechnology MicroRNA-21 as Therapeutic Target in Cancer and Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery The Possibility of Novel Antiplatelet Peptides: The Physiological Effects of Low Molecular Weight HSPs on Platelets
Current Pharmaceutical Design Pathophysiological and Clinical Aspects of Iron Chelation Therapy in MDS
Current Pharmaceutical Design New Perspectives Regarding Anaplastic Thyroid Carcinoma Approach Improvement
Endocrine, Metabolic & Immune Disorders - Drug Targets The Impact of Self-Assembly in Medicine and Pharmacology
Current Pharmaceutical Analysis Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability
Current Neuropharmacology Role of Islet-, Gut-, and Adipocyte-Derived Hormones in the Central Control of Food Intake and Body Weight: Implications for an Integrated Neurohormonal Approach to Obesity Pharmacotherapy
Current Diabetes Reviews Cellulose Template Assembled Synthetic Peptides as Molecular Receptors
Current Protein & Peptide Science Embryonic Stem Cell-Based Screen for Small Molecules: Cluster Analysis Reveals Four Response Patterns in Developing Neural Cells
Current Medicinal Chemistry Fc Receptors as Potential Targets for the Treatment of Allergy, Autoimmune Disease and Cancer
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Advances in the Treatment of Neurodegenerative Disorders Employing Nanoparticles
Recent Patents on Drug Delivery & Formulation Pathology and Development - Developmental Systems for Target Validation and Drug Screening in Osteoarthritis
Drug Design Reviews - Online (Discontinued) Evaluation of Current Pharmacological Treatment Options in the Management of Rett Syndrome: From the Present to Future Therapeutic Alternatives.
Current Clinical Pharmacology Current Protein-based Anti-angiogenic Therapeutics
Mini-Reviews in Medicinal Chemistry Potential Clinical Applications of (-), (+) and (±)-Z-Bisdehydrodoisynolic Acids in Metabolic Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Complex Obesity
Current Pediatric Reviews Current Development in Encapsulated Cell Therapy for Degenerative Retinopathies
Current Tissue Engineering (Discontinued) Prediction of Cancer Rescue p53 Mutants In Silico Using Naïve Bayes Learning Methodology
Protein & Peptide Letters Epigenetic Regulation in Particulate Matter-Mediated Cardiopulmonary Toxicities: A Systems Biology Perspective
Current Pharmacogenomics and Personalized Medicine